Actuate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers. The company's lead investigational drug is elraglusib, a GSK-3β inhibitor.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.